MMJ PhytoTech Ltd (ASX:MMJ) Annual Report to Shareholders
MMJ PhytoTech Ltd (ASX:MMJ) provides the Company's 2017 Annual Report to shareholders.
Companies in the News
Drugs & OTC
Queensland Bauxite Ltd (ASX:QBL) Anticipated Cashflow from MCL Investment
The Board of Queensland Bauxite (ASX:QBL) is most excited to announce that via its subsidiary Medical Cannabis Ltd, the initial sample range of hemp products under the name Vitahemp, will be ready for introduction to the Australian market in November 2017. Hemp foods are an extremely nutritious form of food product made from low THC Cannabis.
Anatara Lifesciences Ltd (ASX:ANR) Investor Presentation
Anatara Lifesciences (ASX:ANR) is pleased to release its latest institutional roadshow presentation and market update that will be delivered to investors this week by CEO & Chairman, Dr Mel Bridges and Co-Founder and Chief Scientific Officer, Dr Tracey Mynott.
MMJ PhytoTech Ltd (ASX:MMJ) Harvest One Operational Update
MMJ PhytoTech Limited (ASX:MMJ) is pleased to advise that Harvest One Cannabis Inc. (CVE:HVST), which is 59% owned by MMJ, has released an update on its wholly-owned subsidiary United Greeneries Ltd..
Queensland Bauxite Ltd (ASX:QBL) Engagement of Israeli Research Organisation for the Development of Medical Cannabis Products
The Board of Queensland Bauxite Limited (ASX:QBL) is pleased to announce that further to the significant progress that its subsidiary Medical Cannabis Limited has been making in its business and product development, EndoCRO Ltd an iCAN:Israel-Cannabis company, has been selected as a research and product development arm on a contract basis.
Queensland Bauxite Ltd (ASX:QBL) MDL Granted on South Johnstone Bauxite Project
The Board of Queensland Bauxite (ASX:QBL) is pleased to announce that the Department of Natural Resources and Mines has now formally approved the Mineral Development License for the South Johnstone Bauxite Project.
MMJ PhytoTech Ltd (ASX:MMJ) Strategy Expansion
MMJ PhytoTech Limited (ASX:MMJ) is pleased to provide the following update on the Company's strategic direction and proposed name change to "MMJ Capital Limited".
◂Previous Page
Drugs & OTC Next Page▸
Banking & Finance
- Locksley Resources Limited (ASX:LKY) Qualifies for Trading on U.S. OTCQX Market
- Resolution Minerals Ltd (ASX:RML) OTCQB Listing Successfully Completed
- VIDEO: Lion Selection Group Ltd (ASX:LSX) CEO Hedley Widdup and Sean Russo Talk at the Australian Gold Conference 2024
- VIDEO: The Australian Gold Conference 2024 - Education Evening with Expert Panel
- Lithium Universe Ltd (ASX:LU7) Finalises Frankfurt and US OTC Listing
- ISX Financial Reports Strong Q2 2024 Results, Highlighting Robust Growth and Innovation
Oil Gas & Energy
- Deep Yellow Limited (ASX:DYL) Managing Director and CEO Commencement Date
- Deep Yellow Limited (ASX:DYL) Exploration Update
- Central Petroleum Limited (ASX:CTP) Appoints Mr Joel Riddle as Director
- Central Petroleum Limited (ASX:CTP) Strategic Expansion Into the Cooper and Otway Basins
- Beetaloo Energy Australia Limited (ASX:BTL) Carpentaria-5H Flow Testing Update
- Central Petroleum Limited (ASX:CTP) Sub-Salt Exploration Permit Sale Update
Life Sciences
- Proteomics International Laboratories Ltd (ASX:PIQ) Appointment of CEO and Managing Director
- BPH Energy Limited (ASX:BPH) Raises $1.2M to Accelerate Funding of Hydrocarbon and Cortical Investments
- Proteomics International Laboratories Ltd (ASX:PIQ) US Lab Accredited by College of American Pathologists - Extends Precision Dx Lab
- Proteomics International Laboratories Ltd (ASX:PIQ) US Patent Secured for PromarkerEso Diagnostic Test for Throat Cancer
- Proteomics International Laboratories Ltd (ASX:PIQ) PromarkerD Changes How Doctors Manage Diabetic Kidney Disease - Study Published
- Proteomics International Laboratories Ltd (ASX:PIQ) PromarkerD Predicts Risk of DKD in Aboriginal Australians
Social Media
